656 Exploratory platform trial to evaluate immunotherapy combinations with chemotherapy for the treatment of patients with previously untreated metastatic pancreatic adenocarcinoma (REVOLUTION)

Jaclyn Lyman; Eileen O’Reilly; Zev Wainberg; George Fisher; Robert Wolff; Andrew Ko; Mark O’Hara; Harshabad Singh; Ravi Amaravadi; Alec Kimmelman; Eric Collison; Danny Khalil; Rosemarie Schmidberger; Christopher Cabanski; Stephen Maddock; Marko Spasic; Deena Maurer; Diane Da Silva; Christopher Perry; Jia Xin Yu; Lacey Padrón; Samantha Bucktrout; Lisa Butterfield; Ramy Ibrahim; Justin Fairchild; Theresa LaVallee; Thomas Lillie; William Hoos; Silvia Boffo; Ute Dugan; Jill O’Donnell-Tormey; Robert Vonderheide

doi:10.1136/jitc-2022-SITC2022.0656

Citation Tools

Regular and Young Investigator Award Abstracts

Clinical Trials In Progress

656 Exploratory platform trial to evaluate immunotherapy combinations with chemotherapy for the treatment of patients with previously untreated metastatic pancreatic adenocarcinoma (REVOLUTION)

Free

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Cite this article as:: Lyman J, O’Reilly E, Wainberg Z, et al

656 Exploratory platform trial to evaluate immunotherapy combinations with chemotherapy for the treatment of patients with previously untreated metastatic pancreatic adenocarcinoma (REVOLUTION)

Journal for ImmunoTherapy of Cancer 2022;10:doi: 10.1136/jitc-2022-SITC2022.0656

Log in using your username and password

Main menu

Log in using your username and password

You are here

Download to a citation manager

Read the full text or download the PDF:

Log in using your username and password